IBDEI0Y8 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15246,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,15247,0)
 ;;=N18.1^^85^844^19
 ;;^UTILITY(U,$J,358.3,15247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15247,1,3,0)
 ;;=3^CKD stage 1 (GFR>=90)
 ;;^UTILITY(U,$J,358.3,15247,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,15247,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,15248,0)
 ;;=N18.2^^85^844^20
 ;;^UTILITY(U,$J,358.3,15248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15248,1,3,0)
 ;;=3^CKD stage 2 (GFR 60-89)
 ;;^UTILITY(U,$J,358.3,15248,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,15248,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,15249,0)
 ;;=N18.3^^85^844^21
 ;;^UTILITY(U,$J,358.3,15249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15249,1,3,0)
 ;;=3^CKD stage 3 (GFR 30-59)
 ;;^UTILITY(U,$J,358.3,15249,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,15249,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,15250,0)
 ;;=N18.4^^85^844^22
 ;;^UTILITY(U,$J,358.3,15250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15250,1,3,0)
 ;;=3^CKD stage 4 (GFR 15-29)
 ;;^UTILITY(U,$J,358.3,15250,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,15250,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,15251,0)
 ;;=N18.5^^85^844^23
 ;;^UTILITY(U,$J,358.3,15251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15251,1,3,0)
 ;;=3^CKD stage 5 (GFR<15)
 ;;^UTILITY(U,$J,358.3,15251,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,15251,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,15252,0)
 ;;=J44.1^^85^844^25
 ;;^UTILITY(U,$J,358.3,15252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15252,1,3,0)
 ;;=3^COPD w/ Acute exacerbation
 ;;^UTILITY(U,$J,358.3,15252,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,15252,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,15253,0)
 ;;=J44.9^^85^844^24
 ;;^UTILITY(U,$J,358.3,15253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15253,1,3,0)
 ;;=3^COPD
 ;;^UTILITY(U,$J,358.3,15253,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,15253,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,15254,0)
 ;;=E11.69^^85^844^33
 ;;^UTILITY(U,$J,358.3,15254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15254,1,3,0)
 ;;=3^Diabetes mellitus,Type 2 w/ Other complications
 ;;^UTILITY(U,$J,358.3,15254,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,15254,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,15255,0)
 ;;=Z86.718^^85^844^31
 ;;^UTILITY(U,$J,358.3,15255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15255,1,3,0)
 ;;=3^DVT,Hx of
 ;;^UTILITY(U,$J,358.3,15255,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,15255,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,15256,0)
 ;;=I82.509^^85^844^30
 ;;^UTILITY(U,$J,358.3,15256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15256,1,3,0)
 ;;=3^DVT,Chr,Unsp lower extremity vein
 ;;^UTILITY(U,$J,358.3,15256,1,4,0)
 ;;=4^I82.509
 ;;^UTILITY(U,$J,358.3,15256,2)
 ;;=^5133628
 ;;^UTILITY(U,$J,358.3,15257,0)
 ;;=R06.00^^85^844^34
 ;;^UTILITY(U,$J,358.3,15257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15257,1,3,0)
 ;;=3^Dyspnea
 ;;^UTILITY(U,$J,358.3,15257,1,4,0)
 ;;=4^R06.00
 ;;^UTILITY(U,$J,358.3,15257,2)
 ;;=^5019180
 ;;^UTILITY(U,$J,358.3,15258,0)
 ;;=R06.09^^85^844^35
 ;;^UTILITY(U,$J,358.3,15258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15258,1,3,0)
 ;;=3^Dyspnea on exertion
 ;;^UTILITY(U,$J,358.3,15258,1,4,0)
 ;;=4^R06.09
 ;;^UTILITY(U,$J,358.3,15258,2)
 ;;=^5019182
 ;;^UTILITY(U,$J,358.3,15259,0)
 ;;=Z59.0^^85^844^36
 ;;^UTILITY(U,$J,358.3,15259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15259,1,3,0)
 ;;=3^Homelessness
